Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data

G M Crippen1

  • 1College of Pharmacy, University of Michigan, Ann Arbor 48109-1065, USA.

Journal of Medicinal Chemistry
|November 5, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward correct protein folding potentials.

Journal of biological physics·2013
Same author

Constructing smooth potential functions for protein folding.

Journal of molecular graphics & modelling·2001
Same author

Evaluation of ligand overlap by atomic parameters.

Journal of chemical information and computer sciences·2001
Same author

A Gaussian statistical mechanical model for the equilibrium thermodynamics of barnase folding.

Journal of molecular biology·2001
Same author

Disulfide recognition in an optimized threading potential.

Protein engineering·2000
Same author

Potential energy function for continuous state models of globular proteins.

Journal of computational biology : a journal of computational molecular cell biology·2000
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same journal

Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

Journal of medicinal chemistry·2026
Same journal

Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

Journal of medicinal chemistry·2026
Same journal

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

Journal of medicinal chemistry·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
See all related articles

EGSITE2 advances receptor site modeling by eliminating the need for molecular simplification. This computational method generates accurate predictive models from minimal specific binding data, reducing subjectivity and enhancing drug design.

Area of Science:

  • Computational chemistry
  • Molecular modeling
  • Drug discovery

Background:

  • Accurate receptor site models are crucial for understanding molecular interactions.
  • Previous methods required extensive simplification of molecular structures.
  • Subjectivity in model generation has been a limitation in computational drug design.

Purpose of the Study:

  • To introduce EGSITE2, an advanced method for calculating receptor site models.
  • To overcome limitations of previous techniques by removing the need for molecular simplification.
  • To provide a more objective and predictive approach to receptor-ligand binding analysis.

Main Methods:

  • EGSITE2 utilizes specific binding data to generate receptor site models.
  • The method automates the process, removing the need for manual clustering of atoms into superatoms.

Related Experiment Videos

  • It identifies multiple models explaining binding data without outliers.

    • Main Results:

    • EGSITE2 significantly simplifies the modeling process compared to EGSITE.
    • The method requires a minimal number of compounds for training set generation.
    • Generated models demonstrate substantial predictive power for various test compounds, including uncertainty estimation.

    Conclusions:

    • EGSITE2 represents a major advancement in receptor site modeling.
    • The method enhances objectivity and predictive accuracy in computational drug design.
    • Validated on diverse biological systems, EGSITE2 shows broad applicability.